6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01691898 [Disease Site] Non-Hodgkin's Lymphoma [Description] 
A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating the Safety and Activity of DCDT2980S in Combination with Rituximab or DCDS4501A in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description